Home News Newly developed drug shows promise against a novel oncogene that supports cancer progression back to News
minute read
In findings recently published in the Journal of Medicinal Chemistry, Daniel LaBarbera, PhD and colleagues describe the optimization of the first lead CHD1L inhibitors (CHD1Li) through drug design and medicinal chemistry.
Topics: Press Coverage
12850 East Montview Boulevard
Aurora, CO 80045
303-724-2882
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
